These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3160046)
61. The use of gene probes to investigate the etiology of hyperlipidaemia and arterial diseases. Humphries SE Acta Cardiol Suppl; 1988; 29():85-95. PubMed ID: 2898851 [No Abstract] [Full Text] [Related]
62. Apolipoprotein E genotype and coronary heart disease. Batalla A; Alvarez R; Hevia S; Reguero JR; Coto E J Am Coll Cardiol; 2001 Jan; 37(1):329-31. PubMed ID: 11153762 [No Abstract] [Full Text] [Related]
63. [Progress in the study of lipoprotein metabolism and atherosclerosis: organ-specific characteristics of lipoprotein metabolic disorders--with special reference to the heart and brain]. Tamachi H; Goto Y Nihon Rinsho; 1988 Mar; 46(3):671-8. PubMed ID: 3404694 [No Abstract] [Full Text] [Related]
64. Abnormal blood lipids: is it environment or is it genes? Hayman LL J Cardiovasc Nurs; 2000 Jan; 14(2):39-49. PubMed ID: 10653275 [TBL] [Abstract][Full Text] [Related]
65. A medical misdemeanor: I harbored evil thoughts about the Fredrickson fat classification. Grouse LD JAMA; 1980 Nov; 244(18):2090-1. PubMed ID: 7001052 [No Abstract] [Full Text] [Related]
66. From Ag phenotyping to molecular genetics: apolipoprotein B, serum lipid levels and coronary artery disease in Finland. Tikkanen MJ; Heliƶ T Clin Genet; 1994 Jul; 46(1 Spec No):71-6. PubMed ID: 7988082 [No Abstract] [Full Text] [Related]
67. Genetic susceptibility to atherosclerosis. Chamberlain JC; Galton DJ Br Med Bull; 1990 Oct; 46(4):917-40. PubMed ID: 1983134 [TBL] [Abstract][Full Text] [Related]
68. Pharmacogenetics of lipid diseases. Ordovas JM Hum Genomics; 2004 Jan; 1(2):111-25. PubMed ID: 15601539 [TBL] [Abstract][Full Text] [Related]
69. DNA polymorphisms of the apolipoprotein genes--their use in the investigation of the genetic component of hyperlipidaemia and atherosclerosis. Humphries SE Atherosclerosis; 1988 Aug; 72(2-3):89-108. PubMed ID: 3063270 [TBL] [Abstract][Full Text] [Related]
70. Causal analysis of family resemblance. Morton NE; Rao DC Prog Clin Biol Res; 1979; 32():431-52. PubMed ID: 534543 [No Abstract] [Full Text] [Related]
71. [Molecular biology of apolipoproteins in genesis of hyperlipidemias and atherosclerosis]. Hata Y Nihon Rinsho; 1993 Jun; 51(6):1668-76. PubMed ID: 8320847 [TBL] [Abstract][Full Text] [Related]
72. Genetics of atherosclerosis. Sing CF; Moll PP Annu Rev Genet; 1990; 24():171-87. PubMed ID: 2088166 [No Abstract] [Full Text] [Related]
74. DNA markers in the hyperlipidaemias and atherosclerosis. Rees A J R Coll Physicians Lond; 1987 Jan; 21(1):51-4. PubMed ID: 3469405 [No Abstract] [Full Text] [Related]
78. The application of molecular biology techniques to the diagnosis of hyperlipidaemia and other risk factors for cardiovascular disease. Committee on Molecular Biology Techniques in Clinical Chemistry of the International Federation of Clinical Chemistry (IFCC). Humphries SE J Int Fed Clin Chem; 1992 Dec; 4(5):208-18. PubMed ID: 10146701 [No Abstract] [Full Text] [Related]
79. Uncovering rare mutations: an unforeseen complication of routine genotyping of APOE. Hegele RA Clin Chem; 1999 Sep; 45(9):1579-81. PubMed ID: 10471671 [No Abstract] [Full Text] [Related]